US scientists claimed that they have come up with an implant in mice, which is able to capture cancer cells. The study has been published in the journal Nature Communication.

According to the researchers, sucking up of CTCs would help prevent their spread and also assist in stopping disease progression.

In order to carry out experiments, the group of scientists created biodegradable disks nearly half-a-centimetre wide, and implanted two in a mouse. The implant that made use of immune cells as enticement also consisted of a scanner in order to detect the existence of trapped cells.

According to Lonnie Shea at Northwestern University in Illinois, the combined systems could help in the early detection of the disease. As per Shea, "The initial benefit is detection -- catching the metastasis before it spreads widely throughout the body. However, the opportunity to reduce burden (of cell spread) can potentially extend the period of time over which therapies may be effective".

RI Technologies came up with a market research report on Circulating Tumor Cells (CTC) Technologies. The report throws light on market of technologies and services that are used for cancer detection. The market is analyzed by cancer type into Prostate, Breast and other, in addition to Function into Prognostics, Diagnostics and Therapy Management.

The report guides CTC markets for the reason that it covers over 150 companies that are involved in CTC studies/screening, products and services. The report provides a lot of information in relation to the topic.